• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碘-131标记的纤连蛋白:用于成像动脉粥样硬化病变和血栓的潜在试剂。

Iodine-131-labeled fibronectin: potential agent for imaging atherosclerotic lesion and thrombus.

作者信息

Uehara A, Isaka Y, Hashikawa K, Kimura K, Kozuka T, Kamada T, Etani H, Yoneda S, Imaizumi M

机构信息

First Department of Internal Medicine, Osaka University Medical School, Japan.

出版信息

J Nucl Med. 1988 Jul;29(7):1264-7.

PMID:3392585
Abstract

Fibronectin is known to interact with fibrin, collagen, etc. We have labeled fibronectin with 131I, and measured its accumulation in the deendothelialized lesion in the rabbit aorta to evaluate it as a candidate for imaging atherosclerotic lesions and thrombi. Accumulation of [131I] fibronectin in the deendothelialized lesion was apparent at 48 hr, and increased at 72 hr after injection of the agent. Our results indicate that radiolabeled fibronectin may be a useful tracer for imaging early atherosclerotic lesion and thrombus.

摘要

已知纤连蛋白可与纤维蛋白、胶原蛋白等相互作用。我们用131I标记了纤连蛋白,并测量其在兔主动脉去内皮损伤部位的蓄积情况,以评估其作为动脉粥样硬化病变和血栓成像候选物的可能性。在注射该试剂后48小时,[131I]纤连蛋白在去内皮损伤部位的蓄积明显,并在72小时时增加。我们的结果表明,放射性标记的纤连蛋白可能是用于早期动脉粥样硬化病变和血栓成像的有用示踪剂。

相似文献

1
Iodine-131-labeled fibronectin: potential agent for imaging atherosclerotic lesion and thrombus.碘-131标记的纤连蛋白:用于成像动脉粥样硬化病变和血栓的潜在试剂。
J Nucl Med. 1988 Jul;29(7):1264-7.
2
Binding of 131I-labeled tissue-type plasminogen activator on de-endothelialized lesions in rabbits.131I标记的组织型纤溶酶原激活剂在兔去内皮病变处的结合情况。
Nuklearmedizin. 1987 Oct;26(5):224-8.
3
Thrombus imaging: a comparison of radiolabeled GC4 and T2G1s fibrin-specific monoclonal antibodies.血栓成像:放射性标记的GC4和T2G1s纤维蛋白特异性单克隆抗体的比较
J Nucl Med. 1990 Jun;31(6):1048-54.
4
Recombinant polypeptides derived from the fibrin binding domain of fibronectin are potential agents for the imaging of blood clots.源自纤连蛋白纤维蛋白结合域的重组多肽是用于血凝块成像的潜在试剂。
Thromb Haemost. 1997 Apr;77(4):796-803.
5
Radiolabelled anti-human fibrin antibody: a new thrombus-detecting agent.放射性标记抗人纤维蛋白抗体:一种新型血栓检测剂。
Lancet. 1977 Feb 26;1(8009):452-4. doi: 10.1016/s0140-6736(77)91944-4.
6
Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit model.
Radiology. 1989 Apr;171(1):223-6. doi: 10.1148/radiology.171.1.2928528.
7
Preparation and use of 123I-labeled highly iodinated fibrinogen for imaging deep-vein thrombi.用于深部静脉血栓成像的123I标记的高碘化纤维蛋白原的制备与应用
J Nucl Med. 1976 May;17(5):397-400.
8
Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.利用铟 - 111标记的自体血小板对人体动脉粥样硬化病变和静脉血栓进行闪烁扫描检测。
Lancet. 1978 Jun 3;1(8075):1185-7. doi: 10.1016/s0140-6736(78)90972-8.
9
Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents.评估靶向凝血酶的DNA适配体作为潜在血栓成像剂的性能。
Nucl Med Biol. 2003 Jan;30(1):61-72. doi: 10.1016/s0969-8051(02)00378-5.
10
Evaluation of indium-111-labeled anti-fibrin antibody for imaging vascular thrombi.用于血管血栓成像的铟-111标记抗纤维蛋白抗体的评估。
J Nucl Med. 1988 Apr;29(4):494-502.

引用本文的文献

1
Progression of detail.
J Nucl Cardiol. 2000 Mar;7(2):177-9. doi: 10.1016/S1071-3581(00)90041-2.
2
In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.使用纤维蛋白结合磁共振成像造影剂对急性和亚急性血栓进行体内分子成像。
Circulation. 2004 Apr 27;109(16):2023-9. doi: 10.1161/01.CIR.0000127034.50006.C0. Epub 2004 Apr 5.
3
Nuclear medicine and atherosclerosis.核医学与动脉粥样硬化
Eur J Nucl Med. 1990;17(3-4):160-78. doi: 10.1007/BF00811446.